Abstract

Central excitatory amino acid (EAA) receptors are most conveniently subdivided into five main classes, most of which, if not all, are heterogeneous: NMDA, AMPA, kainic acid (KAIN), metabotropic, and L-AP4 receptors. The AMPA and KAIN receptors have very similar pharmacology in vivo , and these receptors are often collectively named non-NMDA EAA receptors. The Amanita muscaria constituent, ibotenic acid, which is an analogue of glutamic acid, interacts more or less effectively with all subtypes of EAA receptors. Ibotenic acid has, however, been used as a lead structure for the development of a number of specific ligands for NMDA and AMPA receptors. Thus, the aspartic acid analogue of ibotenic acid, AMAA, is a specific NMDA agonist. Whereas AMPA and 4-AHCP are specific agonists at AMPA receptors, APPA is a partial AMPA agonist, and AMOA is an antagonist at non-NMDA EAA receptors.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.